Sleep Aids Market Size, Share & Trends Analysis Report By Product (Pillows & Mattresses, Sleep Laboratory Services, Medication), By Sleep Disorders (Sleepwalking, Insomnia, Sleep Apnea), By Region, And Segment Forecasts, 2023 To 2030

Sleep disorders can disrupt the natural sleeping patterns and cause symptoms such as daytime sleepiness, affecting a person's daily routine, weight, mental health, and relationships, and even leading to heart disease and diabetes. The common symptoms of sleep disorders include difficulty falling asleep, daytime drowsiness despite getting adequate sleep, and impaired ability to carry out daily activities. Insomnia, sleep apnea, restless legs syndrome, and narcolepsy are some of the most common sleep disorders. Treatment options for sleep disorders include medications such as pitolisant, modafinil, armodafinil, gabapentin, suvorexant, eszopiclone, zolpidem, melatonin, zaleplon, ramelteon, and lemborexant. However, sedatives can cause adverse effects such as hepatotoxicity, allergies, and hematologic reactions, which have led people to choose sleep aid devices over sleeping pills.

Due to several causes, including the increasing prevalence of sleep disorders such as insomnia, restless legs syndrome, sleep apnea, and narcolepsy, the market for sleep aids is predicted to experience significant development. Due to elements including high levels of stress, unhealthy lifestyles, and expectations from the workplace, the prevalence of these disorders has risen recently. The growing understanding of how critical sleep is to maintaining good health and general well-being is also driving the market for sleep aids.

The Sleep and Sleep Disorders Program was developed by the Centers for Disease Control and Prevention (CDC) in response to the growing public health concern around inadequate sleep. The program's objectives are to encourage sound sleep practices and raise public awareness of the harmful effects of sleep disorders, including a greater risk of chronic diseases, poorer productivity, and a lower quality of life. Over 35% of adults, according to the CDC, do not get the recommended seven hours of sleep per night, which worries many Americans. To encourage healthy sleeping habits, the program provides instructional materials, conducts research, and collaborates with healthcare professionals, neighborhood groups, and other stakeholders. The introduction of wearable monitors and sensors is a crucial factor boosting the market for sleep aids. These tools are used, among other things, to identify breathing patterns, track sleep patterns, and watch heart rate. Such devices have become increasingly common because of their accessibility and simplicity of use, especially among tech-savvy people.

The rise in demand for sleep aids, the prevalence of sleep disorders, including sleep apnea, the availability of cutting-edge healthcare facilities with skilled medical staff, and the large financial investments made by governments in the healthcare system are all factors contributing to the expansion. The market is also expanding pertaining to a significant number of R&D activities and the presence of important players.

Sleep Aids Market Segmentation

• By Product

  • Pillows and Mattresses

  • Sleep Laboratory Services

  • Medication

  • Others

• By Sleep Disorders

  • Restless Leg Syndrome

  • Sleepwalking

  • Insomnia

  • Sleep Apnea

  • Narcolepsy

  • Other Sleep Disorders

• By Region

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

  • APAC   

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA (Middle East and Africa)  

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

• Key players

  • Cadwell Industries, Inc.

  • Compumedics Limited

  • Drive DeVilbiss International

  • GSK plc.

  • Merck & Co., Inc.

  • Natus Medical Incorporated.

  • Koninklijke Philips N.V.

  • Pfizer Inc.

  • Sanofi

  • AstraZeneca